Home Fast Track My Amedeo FAQ About Flying Publisher   

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Diabetes
Subscription from Paris

Request access to your Amedeo Management Center.



Your AMEDEO page is free of charge.

This policy was made possible thanks to a media sponsorship by Boehringer Ingelheim.


2018-05-28

To download data for further processing, check single articles, then select "Medline format" and "Text only".

Abstract format   Medline format Web site   Text only

  1. Monlun M, Hugo M, Blanco L, Mohammedi K, et al.
    Nerve action potential amplitudes, a robust marker of diabetic peripheral neuropathy.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13690.
    PubMed - Related Articles    Abstract available

  2. Mamoulakis D, Vrouvaki F, Louvari V, Galanakis E, et al.
    Incidence of childhood Type 1 diabetes mellitus in Crete.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13681.
    PubMed - Related Articles    Abstract available

  3. Sellman A, Katzman P, Andreasson S, Londahl M, et al.
    Presence of chronic diabetic foot ulcers is associated with more frequent and more advanced retinopathy.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13682.
    PubMed - Related Articles    Abstract available

  4. Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ, et al.
    Diabetes-related lower-extremity complications are a leading cause of the global burden of disability.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13680.
    PubMed - Related Articles    Abstract available

  5. Thomsen RW, Nicolaisen SK, Adelborg K, Svensson E, et al.
    Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13687.
    PubMed - Related Articles    Abstract available

  6. Li YG, Pastori D, Lip GYH.
    Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13685.
    PubMed - Related Articles    Abstract available

  7. Graham-Rowe E, Lorencatto F, Lawrenson JG, Burr JM, et al.
    Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13686.
    PubMed - Related Articles    Abstract available

  8. Laffel L.
    Lost in transition: finding a path forward for young adults with Type 1 diabetes.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13684.
    PubMed - Related Articles    Abstract available

  9. Dojki FK, Bakris GL.
    Hyperkalaemia in diabetes: a silent risk predicting poor outcomes.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13683.
    PubMed - Related Articles    Abstract available

  10. Tofte N, Lindhardt M, Adamova K, Beige J, et al.
    Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
    Diabet Med. 2018 May 21. doi: 10.1111/dme.13669.
    PubMed - Related Articles    Abstract available

  11. .
    In This Issue of Diabetes.
    Diabetes. 2018;67:1033-1034.
    PubMed - Related Articles

  12. Hanssen NMJ, Westerink J, Scheijen JLJM, van der Graaf Y, et al.
    Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Diabetes Care. 2018 May 21. pii: dc18-0159. doi: 10.2337/dc18-0159.
    PubMed - Related Articles    Abstract available

  13. Suissa S.
    Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e109-e110.
    PubMed - Related Articles

  14. Thuresson M, Cavender MA, Fu AZ, Wilding JP, et al.
    Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e106-e108.
    PubMed - Related Articles

  15. Nystrom T, Bodegard J, Nathanson D, Thuresson M, et al.
    Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e104-e105.
    PubMed - Related Articles

  16. Kelly CB, Hookham MB, Yu JY, Jenkins AJ, et al.
    Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.
    Diabetes Care. 2018;41:e102-e103.
    PubMed - Related Articles

  17. Foussard N, Cougnard-Gregoire A, Rajaobelina K, Delcourt C, et al.
    Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.
    Diabetes Care. 2018;41:e101.
    PubMed - Related Articles

  18. Bress AP, Papademetriou V, Feinglos MN.
    Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408.
    Diabetes Care. 2018;41:e90-e91.
    PubMed - Related Articles

  19. Neves JS, Bigotte Vieira M, Leitao L, Viegas Dias C, et al.
    Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408.
    Diabetes Care. 2018;41:e88-e89.
    PubMed - Related Articles

  20. Buckley LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, et al.
    Response to Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.
    Diabetes Care. 2018;41:e86-e87.
    PubMed - Related Articles

  21. Mi MY, Mukamal KJ.
    Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.
    Diabetes Care. 2018;41:e84-e85.
    PubMed - Related Articles

  22. Lamprea-Montealegre JA, de Boer IH.
    Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes.
    Diabetes Care. 2018;41:1132-1133.
    PubMed - Related Articles

  23. .
    In This Issue of Diabetes Care.
    Diabetes Care. 2018;41:1119-1120.
    PubMed - Related Articles

  24. Rickels MR, DuBose SN, Toschi E, Beck RW, et al.
    Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Diabetes Care. 2018 May 18. pii: dc18-0051. doi: 10.2337/dc18-0051.
    PubMed - Related Articles    Abstract available

  25. Mathieu C.
    Are We There Yet? Finding Ways to Work Together on T1D.
    Diabetes Care. 2018;41:667-669.
    PubMed - Related Articles

  26. Riddle MC, Miller ME.
    Scientific Exploration With Continuous Monitoring Systems: An Early Assessment of Arrhythmias During Hypoglycemia.
    Diabetes Care. 2018;41:664-666.
    PubMed - Related Articles

  27. Ottosson F, Smith E, Melander O, Fernandez C, et al.
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed - Related Articles    Abstract available

  28. Marathe CS, Rayner CK, Wu T, Jones KL, et al.
    Gastric Emptying and the Personalized Management of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996517. doi: 10.1210/jc.2018-00849.
    PubMed - Related Articles

  29. Bennett PH.
    Diabetes mortality in the USA: winning the battle but not the war?
    Lancet. 2018 May 18. pii: S0140-6736(18)30843.
    PubMed - Related Articles

  30. Gregg EW, Cheng YJ, Srinivasan M, Lin J, et al.
    Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.
    Lancet. 2018 May 18. pii: S0140-6736(18)30314.
    PubMed - Related Articles    Abstract available



Thank you for your interest in scientific medicine.


Design: